Welcome to our dedicated page for Strive SEC filings (Ticker: ASST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Strive, Inc. (Nasdaq: ASST) SEC filings page on Stock Titan provides direct access to the company’s official disclosures as filed with the U.S. Securities and Exchange Commission. Strive uses these filings to report on its Bitcoin treasury activities, capital structure decisions, preferred equity terms, and material corporate events, giving investors a primary source of regulatory information about ASST.
As an asset management Bitcoin treasury company, Strive’s filings often focus on digital asset holdings and financing. Form 8-K current reports describe large Bitcoin purchases funded through PIPE proceeds, warrant exercises, and the issuance of its Variable Rate Series A Perpetual Preferred Stock (SATA). These filings disclose aggregate Bitcoin holdings, acquisition costs, and the company’s view of its position among corporate Bitcoin holders.
Strive’s SEC documents also explain the detailed terms of the SATA Stock. Through 8-Ks and related exhibits, the company outlines the variable dividend structure, liquidation preference, seniority relative to common stock, compounded dividends on unpaid amounts, redemption features, and investor protections that apply if certain events occur. Additional filings report monthly dividend declarations on SATA and discuss the expected return-of-capital tax treatment of these distributions, including the company’s statement that it does not have accumulated earnings and profits.
Investors can also use Strive’s filings to review quarterly and transactional disclosures. Form 8-Ks reference quarterly financial results, the consummation of a reverse acquisition of Asset Entities Inc., and the registration of large blocks of Class A common stock for resale. Other filings describe amendments to Strive’s articles of incorporation and bylaws, changes in board composition, and the registration statements related to its proposed all-stock merger with Semler Scientific, Inc.
On Stock Titan, these filings are supplemented with AI-powered summaries that highlight key points from lengthy documents such as registration statements, 8-Ks, and prospectus supplements. Users can quickly see what each filing covers—whether it is a Bitcoin purchase disclosure, a SATA dividend update, or a merger-related communication—while retaining the ability to read the full text for deeper analysis. This makes the ASST filings page a practical starting point for understanding Strive’s regulatory history, capital markets activity, and Bitcoin-focused strategy.
Strive, Inc. furnished an 8‑K to announce that it issued a press release with financial results for the quarter ended September 30, 2025. The press release is included as Exhibit 99.1 and dated November 14, 2025.
The company states the Item 2.02 information, including Exhibit 99.1, is furnished and not deemed filed under Section 18 of the Exchange Act or incorporated by reference except as expressly provided. The report was signed by Chief Executive Officer Matthew Cole.
Strive, Inc. reposted a communication on X from board member Pierre Rochard regarding its proposed business combination with Semler Scientific (SMLR). The notice reiterates forward‑looking statement cautions and points investors to SEC filings for details.
Strive has filed a Form S-4 to register Class A common stock to be issued in connection with the transaction, which will include an information statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive. A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. The communication also outlines where to access the S-4, related amendments, and future materials, and clarifies that this is not an offer to sell or solicit securities.
Strive, Inc. released a communication under Rule 425 about its proposed business combination with Semler Scientific, Inc. (SMLR). The message includes a broad forward‑looking statements disclaimer highlighting uncertainties around timing, integration and expected strategic and financial benefits.
Strive has filed a Registration Statement on Form S‑4 that will include an information statement of Strive, a proxy statement of Semler Scientific and a prospectus of Strive. Semler Scientific stockholders will receive a definitive document to vote on the transaction, and investors are urged to read the Registration Statement and related materials when available on the SEC’s website. The communication also states it is not an offer or solicitation to sell securities.
Strive, Inc. issued a Rule 425 communication about its proposed business combination with Semler Scientific, Inc. (SMLR). Strive has filed a Form S-4 to register Class A common stock to be issued in the transaction, which will include an information statement for Strive, a proxy statement for Semler Scientific, and a prospectus for Strive.
A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. The companies emphasize forward-looking statement cautions, outline where investors can access SEC filings, note that directors and officers may be participants in the proxy solicitation, and clarify that this communication is not an offer or solicitation.
Strive, Inc. reposted on X a communication about its proposed business combination with Semler Scientific (SMLR). The message includes a forward‑looking statements caution and notes that Strive has filed a Form S‑4 to register Class A common stock to be issued in the transaction.
A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler stockholders to seek their approval, and investors are urged to read these materials when available. Documents will be accessible free of charge on the SEC’s website and via company investor relations pages. The communication also states it is not an offer or solicitation to buy or sell securities.
Strive, Inc. filed a Rule 425 communication regarding its proposed business combination with Semler Scientific (SMLR), noting that CEO Matthew Cole reposted the communication on X.com on November 12, 2025.
Strive has filed a Form S-4 registration statement to register Class A common stock to be issued in connection with the transaction. The S-4 will include an information statement/proxy statement/prospectus, and a definitive version will be sent to Semler stockholders to seek approval of the proposed transaction.
The notice includes extensive forward‑looking statement disclaimers and directs investors to read the S-4 and related materials when available, which will be accessible free of charge on the SEC’s website and the companies’ investor sites.
Strive, Inc. announced a Rule 425 communication regarding its proposed business combination with Semler Scientific. Strive has filed a Form S-4 to register Class A common stock to be issued in connection with the transaction, which will include an information statement/proxy statement/prospectus. Semler Scientific stockholders will receive definitive materials to vote on the proposed transaction.
The notice includes a forward-looking statements caution, identifies potential proxy solicitation participants, and clarifies this is not an offer or solicitation. Related documents will be available free of charge at SEC.gov and the companies’ investor relations websites.
Strive, Inc. filed a Rule 425 communication about its proposed business combination with Semler Scientific (SMLR). The notice reiterates standard forward‑looking statement cautions and directs investors to SEC filings for details.
Strive has filed a Registration Statement on Form S-4 to register Class A common stock to be issued in the transaction, with related Information Statement/Proxy Statement/Prospectus materials, including versions filed on August 6, 2025 and October 10, 2025. A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek approval of the proposed transaction.
The communication emphasizes that it is not an offer to sell or solicit an offer to buy securities. Investors are urged to read the Registration Statement and related materials when available, accessible free of charge on the SEC’s website and company investor sites.
Strive, Inc. issued a Rule 425 communication about its proposed business combination with Semler Scientific, Inc. (SMLR). Strive has filed a Registration Statement on Form S‑4 to register the Class A common stock it would issue in the transaction, which will include an information statement of Strive, a proxy statement for Semler Scientific stockholders, and a prospectus of Strive.
A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. The communication includes forward‑looking statements subject to risks and uncertainties referenced in prior SEC filings of both companies. It also notes that directors, officers, and certain employees of both companies may be deemed participants in the proxy solicitation.
This notice reiterates that it is not an offer or solicitation to sell or buy securities. Investors are urged to read the S‑4 and related materials when available on the SEC’s website and company investor sites.
Strive, Inc. issued a Rule 425 communication regarding its proposed business combination with Semler Scientific. Strive has filed a Form S-4 to register Class A common stock to be issued in connection with the transaction. The registration will include an information statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive. A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval.
The communication contains forward-looking statement disclaimers and directs investors to SEC filings for risks and details, including Strive’s S-4 and related reports and Semler Scientific’s 10-K and 10-Qs. It notes that directors and officers of both companies may be deemed participants in the proxy solicitation and provides links to obtain documents free of charge. It also states this is not an offer to sell securities.